anti-Mastermind-Like 2 (Drosophila) (MAML2) Anticorps

Acts as a transcriptional coactivator for NOTCH proteins. De plus, nous expédions et beaucoup plus de produits pour cette protéine.

afficher tous les anticorps Gène GeneID UniProt
MAML2 270118  
MAML2 689844  
MAML2 84441 Q8IZL2
Comment commander chez anticorps-enligne
  • +1 877 302 8632
  • +1 888 205 9894 (toll-free)
  • Commandez enligne

Top anti-MAML2 Anticorps sur

Showing 10 out of 60 products:

Catalogue No. Reactivité Hôte Conjugué Application Images Quantité Livraison Prix Détails
Boeuf (Vache) Lapin Inconjugué WB Host:  Rabbit  Target Name:  Maml2  Sample Type:  Mouse Stomach lysates  Antibody Dilution:  1.0ug/ml 100 μL 2 to 3 Days
Cobaye Lapin Inconjugué WB WB Suggested Anti-5930431H10 Antibody Titration:  0.2-1 ug/ml  Positive Control:  Mouse Kidney 100 μL 2 to 3 Days
Souris Lapin Inconjugué WB 100 μL 11 to 14 Days
Humain Souris Inconjugué FACS, IF, IHC (p) IHC testing of FFPE human bladder carcinoma with MAML2 antibody (clone MMLP2-1). IHC testing of FFPE human colon carcinoma with MAML2 antibody (clone MMLP2-1). 100 μg 2 to 3 Days
Humain Lapin Inconjugué WB 100 μL 11 to 14 Days
Humain Lapin Inconjugué ELISA, WB   100 μL 11 to 13 Days
Humain Souris CF®405S FACS, IF, IHC, ISt, WB   100 μL 3 to 4 Days
Humain Souris CF405M FACS, IF, IHC, ISt, WB   100 μL 3 to 4 Days
Humain Souris CF®640R FACS, IF, IHC, ISt, WB   100 μL 3 to 4 Days
Humain Souris CF®647 FACS, IF, IHC, ISt, WB   100 μL 3 to 4 Days

anti-MAML2 Anticorps mieux référencés

  1. Human Polyclonal MAML2 Primary Antibody pour IHC, IP - ABIN151565 : Oyama, Harigaya, Sasaki, Okamura, Kokubo, Saga, Hozumi, Suganami, Tamura, Nagase, Koga, Nishimura, Sakamoto, Sato, Yoshida, Kitagawa: Mastermind-like 1 (MamL1) and mastermind-like 3 (MamL3) are essential for Notch signaling in vivo. dans Development (Cambridge, England) 2011 (PubMed)

Plus d’anticorps contre MAML2 partenaires d’interaction

Human Mastermind-Like 2 (Drosophila) (MAML2) interaction partners

  1. Pancreatic mucoepidermoid carcinoma does not have CRTC1/3-MAML2 fusion gene and MAML2 gene rearrangement.

  2. Two cases of breast mucoepidermoid carcinomas harboring CRTC1-MAML2 fusions are reported

  3. The expression of the MAML2 gene in penile cancers from men receiving first-line cisplatin-based chemotherapy predicted overall survival independent of clinical factors.

  4. LINC00473 acts as a promising biomarker and therapeutic target for human CRTC1-MAML2-positive Mucoepidermoid carcinomas.

  5. CRTC3-MAML2 gene fusion occurs in hidradenomas.

  6. findings suggest further characterization of MECs is needed before considering the CRTC1/3-MAML2 gene fusion as a prognostic biomarker

  7. It is, to our knowledge, the first case of B acute lymphoblastic leukemia with this fusion gene. At the molecular level, two rearrangements were detected using RNA sequencing juxtaposing exon 7 to exon 2 and exon 9 to intron 1-2 of the KMT2A and MAML2 genes respectively, and one rearrangement using Sanger sequencing juxtaposing exon 8 and exon 2.

  8. we demonstrated that MDM2 is frequently overexpressed in clear cell carcinomas, and that MDM2 overexpression is associated with poor prognosis.

  9. Warthin-like mucoepidermoid carcinoma (MEC), and now a ciliated form of MEC, are newly described variants of a common salivary gland carcinoma. MAML2 rearrangements were identified in all cases. These unusual variants appear to consistently harbor MAML2 fusions-a finding that establishes a clear link to conventional MEC.

  10. MECT1-MAML2 fusion transcript is a driver genetic event in the pathogenesis of primary bronchopulmonary mucoepidermoid carcinoma

  11. A subgroup of MAML2 fusion-negative mucoepidermoid carcinomas are actually clear cell carcinoma of the salivary gland with EWSR1 translocation.

  12. This condensed chromatin structure is associated with binding of DNMT3B and decreased occupancy of OCT1 transcription factor at MAML2 enhancer, suggesting a role of DNMT3B in increasing methylation of MAML2 after stilbenoid treatment.

  13. revealing neither correlation between the cellular composition and CRTC1-MAML2 fusions nor presence of CRTC3-MAML2 fusions in cutaneous hidradenoma

  14. MAML2 rearrangement is common and specific for MEC, which makes it a useful diagnostic tool. MAML2 rearrangement also predicts a favorable prognosis.

  15. Detection of the CRTC1/MAML2 fusion transcript provides useful information for MEC diagnosis but is not associated with differences in survival outcomes.

  16. The molecular basis underlying CRTC1-MAML2 oncogenic functions were identified in mucoepidermoid carcinoma cells.

  17. SNPs in Notch pathway genes may be predictors of cutaneous melanoma disease-specific survival.

  18. We identified MAML2 rearrangements in five of nine odontogenic cysts lined by mucus-secreting cells

  19. Translocation t(11;19)(q14-21;p12-13) in patients with Salivary mucoepidermoid carcinoma was reported , which results in fusion between exons 1 and 2 of MAML2 on chromosome 11q21.Fusion positive, MAML2 re-arrangements are present in 50-70 % of MECs.

  20. The high sensitivity and specificity of MAML2 rearrangement for central mucoepidermoid carcinoma points to its utility as a diagnostic adjunct in separating mucinous cystic lesions of the gnathic bones.

MAML2 profil antigène

Profil protéine

Acts as a transcriptional coactivator for NOTCH proteins. Has been shown to amplify NOTCH-induced transcription of HES1. Potentiates activation by NOTCH3 and NOTCH4 more efficiently than MAML1 or MAML3 (By similarity).

Gene names and symbols associated with MAML2

  • mastermind like 2 (Drosophila) (Maml2) anticorps
  • mastermind-like transcriptional coactivator 2 (Maml2) anticorps
  • mastermind like transcriptional coactivator 2 (MAML2) anticorps
  • 5930431H10 anticorps
  • BC032967 anticorps
  • MAM-3 anticorps
  • MAM2 anticorps
  • MAM3 anticorps
  • MLL-MAML2 anticorps

Protein level used designations for MAML2

mastermind like 2 , mastermind-like 2 , mastermind-like protein 2 , mam-2

270118 Mus musculus
689844 Rattus norvegicus
84441 Homo sapiens
521194 Bos taurus
485116 Canis lupus familiaris
Fournisseurs de qualité sélectionnés pour anti-MAML2 (MAML2) Anticorps
Avez-vous cherché autre chose?